Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 10:44 PM
Study NCT ID:
NCT02875067
Status:
TERMINATED
Last Update Posted:
2020-08-14
First Post:
2016-08-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
Sponsor:
NYU Langone Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-02
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-08
First Submit QC Date:
None
Study First Post Date:
2016-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-29
Results First Submit QC Date:
None
Results First Post Date:
2020-08-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-12
Last Update Post Date:
2020-08-14
Last Update Post Date Type:
ACTUAL